Nuveen Asset Management, LLC Applied Therapeutics Inc. Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 281,028 shares of APLT stock, worth $300,699. This represents 0.0% of its overall portfolio holdings.
Number of Shares
281,028
Previous 261,420
7.5%
Holding current value
$300,699
Previous $2.22 Million
89.29%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding APLT
# of Institutions
80Shares Held
89.6MCall Options Held
152KPut Options Held
186K-
T. Rowe Price Investment Management, Inc. Baltimore, MD18.7MShares$20 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY11.5MShares$12.3 Million0.19% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$12.1 Million4.26% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$8.35 Million1.64% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$7.03 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $51.4M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...